Charter Capital Management’s Eli Lilly LLY Stock Holding History

Charter Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$640K	Sell	553 -63	-10%	-$74.3K	0.29%	31
2026 Q2	$739K	Sell	616 -14	-2%	-$14.3K	0.33%	26
2026 Q1	$580K	Buy	630 +1	+0.2%	+$1.01K	0.29%	30
2025 Q4	$676K	Hold	629	–	–	0.35%	26
2025 Q3	$480K	Hold	629	–	–	0.26%	40
2025 Q2	$491K	Buy	+629	New	+$489K	0.29%	37

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Charter Capital Management's LLY Position: Q3 2026 in Review

Charter Capital Management reduced its Eli Lilly (LLY) stake by 10% in Q3 2026, selling an estimated $74.3K and leaving 553 shares worth $640K. The position accounts for 0.29% of the portfolio, ranked #31.

Charter Capital Management first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. The position peaked at $739K in Q2 2026. 2,398 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Charter Capital Management held 553 shares of Eli Lilly worth $640K as of Q3 2026.
Charter Capital Management sold 63 Eli Lilly shares in Q3 2026, an estimated $74.3K.
Eli Lilly made up 0.29% of Charter Capital Management's portfolio in Q3 2026, its #31 holding.
Charter Capital Management first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
Charter Capital Management's Eli Lilly position peaked at $739K in Q2 2026.
2,398 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Charter Capital Management's 13F filing for Q3 2026, filed 28 Oct 2026.